Establishment Labs Holdings Inc. — News

AlTi Global Inc. acquired a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 14,825 shares of the company's stock, valued at approximately $842,000. AlTi Global Inc. owned about

defenseworld.net - 2026-07-21 03:14:02

JW Asset Management sold 90,533 shares between May 26 and May 28, 2026, generating a transaction value of ~$6.64 million at a weighted average price of around $73.31 per share. The transaction represented 3.04% of the insider's total indirect holdings, reducing indirect ownership from ~2.98 million to ~2.89 million shares.

fool.com - 2026-07-05 17:18:01

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Taylor Harris to its Board of Directors. Mr. Harris brings more than 25 years of experience in corporate finance, executive leadership and board governance across healthcare, medical technology and life sciences companies. He currently serves on t.

businesswire.com - 2026-06-29 08:00:00

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will be added as a member of the US small-cap Russell 2000® Index, effective when the US market opens on June 29th as part of the 2026 Russell indexes reconstitution. Membership in the Russell 2000® Index, which remains in place for half a year beginning 2026, is based on membershi.

businesswire.com - 2026-06-25 08:00:00

Establishment Labs develops advanced silicone implants and medical devices for global plastic surgery markets.

fool.com - 2026-05-30 15:59:19

WEST JORDAN, Utah, May 18, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the appointment of Raj Denhoy to the role of Chief Financial Officer (CFO) effective today. “Route 92 Medical has built a strong position in neurovascular intervention,” said Raj Denhoy, CFO at Route 92 Medical.

globenewswire.com - 2026-05-18 08:00:00

This global medtech firm specializing in advanced implant solutions reported a notable insider sale amid a year of strong share performance.

fool.com - 2026-05-11 21:28:03

Establishment Labs Holdings Inc. (ESTA) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 15:51:21

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.7 per share a year ago.

zacks.com - 2026-05-06 10:30:37

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2026. First Quarter Highlights and Outlook (Unaudited) Revenue of $59.9 million, up 44.7% from Q1 2025, with guidance raised to $266.5 million to $268.5 million $19.6 million of Motiva sales in the United State.

businesswire.com - 2026-05-06 08:00:00

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into a $300 million senior secured term loan facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”). The amended and restated facility refinances the company's existing debt and allows access to additional capital to support ongoi.

businesswire.com - 2026-04-30 08:53:00

Award underscores GameSquare's track record of innovation building next-generation esports platforms FRISCO, TX / ACCESS Newswire / April 30, 2026 / GameSquare Holdings, Inc. (NASDAQ:GAME) ("GameSquare" or the "Company") today announced it has been named the winner of the 2026 ESTA Industry Award in the Esports Innovation category, presented by the Esports Trade Association (ESTA). The award recognizes GameSquare's continued innovation in advancing the esports and gaming ecosystem through its integrated platform, which combines award-winning creative services, data analytics, talent management, and owned media assets to deliver measurable outcomes for brands and publishers.

accessnewswire.com - 2026-04-30 08:00:00

Establishment Labs (NASDAQ: ESTA - Get Free Report) and Intelligent Bio Solutions (NASDAQ: INBS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, risk, dividends and valuation. Earnings and Valuation This table compares

defenseworld.net - 2026-04-27 01:12:48

Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have been given an average rating of "Moderate Buy" by the eight research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have given

defenseworld.net - 2026-04-24 02:12:52

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2026, before the market opens on Wednesday, May 6, 2026, and will host a conference call at 8:30 am ET that day to discuss those results. To participate in the conference call, Dial: 877-407-8037 (US & Cana.

businesswire.com - 2026-04-23 08:00:00